Navigation Links
U.K. Backs Program To Improve Drug Access in Developing Countries

United Kingdom International Development Secretary Hilary Benn on Wednesday announced that the country will support the Medicines// Transparency Alliance -- an initiative that aims to improve access to quality medical care, including HIV/AIDS, tuberculosis and malaria treatment, in developing countries -- the Financial Times reports.

MeTA aims to improve access to quality medicine by providing information about HIV/AIDS, malaria and TB drugs to governments, not-for-profit organizations and pharmaceutical companies, the Times reports.

The initiative also aims to increase efficiency, bolster drug procurement and fight corruption by making information about drug costs public. MeTA -- which is funded by a 25 million pounds, or about $50 million, five-year grant from the Department for International Development -- will draw on DFID's experience with its existing Extractive Industries Transparency Initiative, which aims to improve the quality of public procurement for medicines.

In addition, MeTA hopes to increase awareness about drug procurement processes and other logistical issues, according to the Times. "We want better information on the price of drugs, their availability and quality," Benn said, adding, "We know that there are big mark-ups on drugs, drugs are not always available, distribution is not working and the quality is often not effective."

The Bill & Melinda Gates Foundation and other donors are considering lending support to MeTA. Pilot projects are scheduled to be launched this summer in nine countries -- including Ghana, Jordan, Kyrgyzstan, Peru and the Philippines -- the Times reports. MeTA aims to draw on the experiences in the pilot countries and launch the initiative worldwide by the end of next year.

Source-Kaiser Family Foundation
'"/>




Page: 1

Related medicine news :

1. AMA Backs Advance Care Planning by Patients
2. Unbelted Backseat Passengers Produce Deadly Results
3. Thailand Backs Off Threat to Break Drug Patents
4. E.U. Panel Backs Novartis Mock-up Pandemic Flu Vaccine
5. AMA Backs Red Cross Blood Service Campaign For More Blood Donors
6. Computer Program can assist to detect Heart Attack
7. Self-Management Program Beneficial for Back Pain
8. Self-Management Program Beneficial for Back Pain
9. Disease Management Programs – Effective for Heart Patient
10. Suicide Prevention Program – Having its Intended Effec
11. Cardiac – Rehabilitation Programs Beneficial for Heart Patient
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... ... On Tuesday, April 26, 2016 members of the HomeTown Health network, a ... Deal on SB 258, the “Rural Health Care Relief” Bill. , The bill, which ... to individuals and corporations which donate directly to a “rural hospital” in Georgia, and ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of skin ... blame for the majority of skin cancer deaths. More than 10,000 people are expected to ... at diagnosis is 62, it is the one of the most commonly diagnosed cancers in ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral drug ... the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... in New York . Nadav Kidron ... the conference. Presentation Details:   ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology: